Long-Term Survival of Patients with Metastatic Non-Small-Cell Lung Cancer over Five Decades

Objective. Novel therapeutics and supportive care improved outcomes for metastatic non-small-cell lung cancer (mNSCLC) patients. Major advances over the past five decades include the introduction of combination chemotherapy, small molecules targeting mutant proteins, especially EGFR, and more recent...

Full description

Bibliographic Details
Main Authors: Jair Bar, Damien Urban, Uri Amit, Sarit Appel, Amir Onn, Ofer Margalit, Tamar Beller, Teodor Kuznetsov, Yaacov Lawrence
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:Journal of Oncology
Online Access:http://dx.doi.org/10.1155/2021/7836264